Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

eFFECTOR Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues3.61.442.00.0
            Revenue growth148.5%-96.6%  
Cost of goods sold0.00.00.00.0
Gross profit3.61.442.00.0
            Gross margin100.0%100.0%100.0% 
Research and development23.320.021.823.9
General and administrative12.613.44.34.7
EBIT-32.4-31.915.8-28.6
            EBIT margin-912.0%-2230.6%37.7% 
Pre-tax income-22.715.814.6-29.7
Income taxes0.00.00.40.0
            Tax rate0.0%0.0%2.4%0.0%
Net income-22.715.80.2-14.2
            Net margin-637.9%1104.8%0.4% 
 
Diluted EPS($0.55)$0.44$0.06($11.88)
Shares outstanding (diluted)41.236.02.71.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy